Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-01-27 @ 12:36 AM
Study NCT ID:
NCT07177118
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-16
First Post:
2025-09-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risankizumab for Fibrostenotic Crohn's Disease Treatment
Sponsor:
First Affiliated Hospital of Wenzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-06-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-20
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-05
First Submit QC Date:
None
Study First Post Date:
2025-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED